Recombinant DNA Technology - Department of Biochemistry BMC, Sagar
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Recombinant DNA (rDNA) is a form of artificial DNA that is created by combining two or more sequences that would not normally occur together through the process of gene splicing. Recombinant DNA technology is a technology which allows DNA to be produced via artificial means. The procedure has been used to change DNA in living organisms and may have even more practical uses in the future.
Recombinant DNA technology is one of the recent advances in biotechnology, which was developed by two scientists named Boyer and Cohen in 1973.
Stanley N. Cohen , who received the Nobel Prize in Medicine in 1986 for his work on discoveries of growth factors. Stanley N. Cohen (1935–) (top) and Herbert Boyer (1936–) (bottom), who constructed the first recombinant DNA using bacterial DNA and plasmids.
Recombinant DNA Technology 1. The basic procedures of recombinant DNA technology 2. Application of recombinant DNA technology
Recombinant technology begins with the isolation of a gene of interest (target gene). The target gene is then inserted into the plasmid or phage (vector) to form replicon. The replicon is then introduced into host cells to be cloned and either express the protein or not. The cloned replicon is referred to as recombinant DNA. The procedure is called recombinant DNA technology. Cloning is necessary to produce numerous copies of the DNA since the initial supply is inadequate to insert into host cells.
Cloning——In classical biology, a clone is a population of identical organisms derived from a single parental organism. For example, the members of a colony of bacterial cells that arise from a single cell on a petridish are clones. Molecular biology has borrowed the term to mean a collection of molecules or cells all identical to an original molecule or cell.
Six steps of Recombinant DNA 1. Isolating (vector and target gene) 2. Cutting (Cleavage) 3. Joining (Ligation) 4. Transforming 5. Cloning 6. Selecting (Screening)
Six basic steps are common to most recombinant DNA experiments 1. Isolation and purification of DNA. Both vector and target DNA molecules can be prepared by a variety of routine methods. In some cases, the target DNA is synthesized in vitro.
2. Cleavage of DNA at particular sequences. As we will see, cleaving DNA to generate fragments of defined length, or with specific endpoints, is crucial to recombinant DNA technology. The DNA fragment of interest is called insert DNA. In the laboratory, DNA is usually cleaved by treating it with commercially produced nucleases and restriction endonucleases.
3. Ligation of DNA fragments. A recombinant DNA molecule is usually formed by cleaving the DNA of interest to yield insert DNA and then ligating the insert DNA to vector DNA (recombinant DNA or chimeric DNA). DNA fragments are typically joined using DNA ligase (also commercially produced). – T4 DNA Ligase
4. Introduction of recombinant DNA into compatible host cells. In order to be propagated, the recombinant DNA molecule (insert DNA joined to vector DNA) must be introduced into a compatible host cell where it can replicate. The direct uptake of foreign DNA by a host cell is called genetic transformation (or transformation). Recombinant DNA can also be packaged into virus particles and transferred to host cells by transfection.
5. Replication and expression of recombinant DNA in host cells. Cloning vectors allow insert DNA to be replicated and, in some cases, expressed in a host cell. The ability to clone and express DNA efficiently depends on the choice of appropriate vectors and hosts.
6. Identification of host cells that contain recombinant DNA of interest. Vectors usually contain some genetic markers, or genes, that allow the selection of host cells that have taken up foreign DNA. The identification of a particular DNA fragment usually involves an additional step—screening a large number of recombinant DNA clones. This is almost always the most difficult step.
DNA cloning in a plasmid vector permits amplificati on of a DNA fragment.
First step: Isolating DNA 1. Vector 2. Target gene
How to get a target genes? 1. Genomic DNA 2. Artificial synthesis 3. PCR amplification 4. RT-PCR
Polymerase chain reaction (PCR) A technique called the polymerase chain reaction (PCR) has revolutionized recombinant DNA technology. It can amplify DNA from as little material as a single cell and from very old tissue such as that isolated from Egyptian mummies, a frozen mammoth, and insects trapped in ancient amber.
method is used to amplify DNA sequences The polymerase chain reaction (PCR) can quickly clone a small Initial sample of DNA in a DNA segment test tube Number of DNA molecules
PCR primers
RT-PCR Reverse transcription polymerase chain reaction (RT-PCR) is a variant of polymerase chain reaction (PCR. In RT-PCR, however, an RNA strand is first reverse transcribed into its DNA complement (complementary DNA, or cDNA) using the enzyme reverse transcriptase, and the resulting cDNA is amplified using traditional. – Template:RNA – Products: cDNA
Vectors- Cloning Vehicles Cloning vectors can be plasmids, bacteriophage, viruses, or even small artificial chromosomes. Most vectors contain sequences that allow them to be replicated autonomously within a compatible host cell, whereas a minority carry sequences that facilitate integration into the host genome.
All cloning vectors have in common at least one unique cloning site, a sequence that can be cut by a restriction endonuclease to allow site-specific insertion of foreign DNA. The most useful vectors have several restriction sites grouped together in a multiple cloning site (MCS) called a polylinker.
Types of vector 1. Plasmid Vectors 2. Bacteriophage Vectors 3. Virus vectors 4. Shuttle Vectors--can replicate in either prokaryotic or eukaryotic cells. 5. Yeast Artificial Chromosomes as Vectors
Plasmid Vectors Plasmids are circular, double-stranded DNA (dsDNA) molecules that are separate from a cell’s chromosomal DNA. These extra chromosomal DNAs, which occur naturally in bacteria and in lower eukaryotic cells (e.g., yeast), exist in a parasitic or symbiotic relationship with their host cell.
Plasmid
Plasmids can replicate autonomously within a host, and they frequently carry genes conferring resistance to antibiotics such as tetracycline, ampicillin, or kanamycin. The expression of these marker genes can be used to distinguish between host cells that carry the vectors and those that do not
pBR322 pBR322 was one of the first versatile plasmid vectors developed; it is the ancestor of many of the common plasmid vectors used in biochemistry laboratories. pBR322 contains an origin of replication (ori) and a gene (rop) that helps regulate the number of copies of plasmid DNA in the cell. There are two marker genes: confers resistance to ampicillin, and confers resistance to tetracycline. pBR322 contains a number of unique restriction sites that are useful for constructing recombinant DNA.
pBR322 1. Origin of replication 2. Selectable marker 3. unique restriction sites
Enzymes 1. Restriction endonuclease, RE 2. DNA ligase 3. Reverse transcriptase 4. DNA polymerase, DNA pol 5. Nuclease 6. Terminal transferase Restriction Enzymes and DNA Ligases Allow Insertion of DNA Fragments into Cloning Vectors
Restriction enzymes cleave DNA The same sequence of bases is found on both DNA strands, but in opposite orders. GAATTC CTTAAG This arrangement is called a palindrome. Palindromes are words or sentences that read the same forward and backward. form sticky ends: single stranded ends that have a tendency to join with each other ( the key to recombinant DNA)
Restriction Enzymes Cut DNA Chains at Specific Locations Restriction enzymes are endonucleases produced by bacteria that typically recognize specific 4 to 8bp sequences, called restriction sites, and then cleave both DNA strands at this site. Restriction sites commonly are short palindromic sequences; that is, the restriction-site sequence is the same on each DNA strand when read in the 5′ → 3′ direction.
Cut out the gene Restriction enzymes
Restriction enzymes Restriction enzymes are named after the bacterium from which they are isolated – For example, Eco RI is from Escherichia coli, and Bam HI is from Bacillus amyloliquefaciens . The first three letters in the restriction enzyme name consist of the first letter of the genus (E) and the first two letters of the species (co). These may be followed by a strain designation (R) and a roman numeral (I) to indicate the order of discovery (eg, EcoRI, EcoRII).
Blunt ends or sticky ends Each enzyme recognizes and cleaves a specific double-stranded DNA sequence that is 4–7 bp long. These DNA cuts result in blunt ends (eg, Hpa I) or overlapping (sticky) ends (eg, BamH I) , depending on the mechanism used by the enzyme. Sticky ends are particularly useful in constructing hybrid or chimeric DNA molecules .
Results of restriction endonuclease digestion. Digestion with a restriction endonuclease can result in the formation of DNA fragments with sticky, or cohesive ends (A) or blunt ends (B). This is an important consideration in devising cloning strategies.
Inserting DNA Fragments into Vectors DNA fragments with either sticky ends or blunt ends can be inserted into vector DNA with the aid of DNA ligases. For purposes of DNA cloning, purified DNA ligase is used to covalently join the ends of a restriction fragment and vector DNA that have complementary ends . The vector DNA and restriction fragment are covalently ligated together through the standard 3 → 5 phosphodiester bonds of DNA. DNA ligase “pastes” the DNA fragments together
Ligation of restriction fragments with complementary sticky ends.
insertional inactivation A method of screening recombinants for inserted DNA fragments. Using the plasmid pBR322, a piece of DNA is inserted into the unique PstI site. This insertion disrupts the gene coding for a protein that provides ampicillin resistance to the host bacterium. Hence, the chimeric plasmid will no longer survive when plated on a substrate medium that contains this antibiotic. The differential sensitivity to tetracycline and ampicillin can therefore be used to distinguish clones of plasmid that contain an insert.
Screening (Strategies) 1. Gel Electrophoresis Allows Separation of Vector DNA from Cloned Fragments 2. Cloned DNA Molecules Are Sequenced Rapidly by the Dideoxy Chain-Termination Method 3. The Polymerase Chain Reaction Amplifies a Specific DNA Sequence from a Complex Mixture 4. Blotting Techniques Permit Detection of Specific DNA Fragments and mRNAs with DNA Probes
A B C M bp —1534 — 994 — 695 — 515 — 377 — 237 Gel Electrophoresis negative charged DNA run to the anode
Southern blot technique can detect a specific DNA fragment in a complex mixture of restriction fragments. Hybridization Radioactive isotope
Types of blotting techniques Southern blotting Southern blotting techniques is the first nucleic acid blotting procedure developed in 1975 by Southern. Southern blotting is the techniques for the specific identification of DNA molecules. Northern blotting Northern blotting is the techniques for the specific identification of RNA molecules. Western blotting Western blotting involves the identification of proteins. Antigen + antibody
Applications of Recombinant DNA Technology
1. Analysis of Gene Structure and Expression 2. Pharmaceutical Products – Drugs – Vaccines 3. Genetically modified organisms (GMO) – Transgenic plants – Transgenic animal 4. Application in medicine 5.
Analysis of Gene Structure and Expression Using specialized recombinant DNA techniques, researchers have determined vast amounts of DNA sequence including the entire genomic sequence of humans and many key experimental organisms. This enormous volume of data, which is growing at a rapid pace, has been stored and organized in two primary data banks: the GenBank at the National Institutes of Health, Bethesda, Maryland, and the EMBL Sequence Data Base at the European Molecular Biology Laboratory in Heidelberg, Germany.
Pharmaceutical Products Some pharmaceutical applications of DNA technology: Large-scale production of human hormones and other proteins with therapeutic uses Production of safer vaccines A number of therapeutic gene products — insulin, the interleukins, interferons, growth hormones, erythropoietin, and coagulation factor VIII—are now produced commercially from cloned genes
Pharmaceutical companies already are producing molecules made by recombinant DNA to treat human diseases. Recombinant bacteria are used in the production of human growth hormone and human insulin
Use recombinant cells to mass produce proteins – Bacteria – Yeast – Mammalian
• Growth hormone • Insulin deficiency – Hormone required to – Faulty pituitary and properly process sugars regulation and fats – Had to rely on cadaver – Treat diabetes source – Now easily produced by – Now easily produced by bacteria bacteria
Subunit Herpes Vaccine
Not always used for good... • High doses of HGH can cause permanent side effects – As adults normal growth has stopped so excessive GH can thicken bones and enlarge organs
Genetically modified organisms (GMO) Use of recombinant plasmids in agriculture – plants with genetically desirable traits • herbicide or pesticide resistant corn & soybean – Decreases chemical insecticide use – Increases production • “Golden rice” with beta-carotene – Required to make vitamin A, which in deficiency causes blindness
Crops have been developed that are better tasting, stay fresh longer, and are protected from disease and insect infestations. “Golden rice” has been genetically modified to contain beta-carotene
Genetic Engineering of Plants Plants have been bred for millennia to enhance certain desirable characteristics in important food crops. Transgenic plants.
The luciferase gene from a firefly is transformed into tobacco plant using the Ti plasmid. Watering the plant with a solution of luciferin (the substrate for firefly luciferase) results in the generation of light by all plant tissues.
Insect-resistant tomato plants The plant on the left contains a gene that encodes a bacterial protein that is toxic to certain insects that feed on tomato plants. The plant on the right is a wild-type plant. Only the plant on the left is able to grow when exposed to the insects.
Transgenic animals
A transgenic mouse Mouse on right is normal; mouse on left is transgenic animal expressing rat growth hormone
Trangenic plants and animals have genes from other organisms. These transgenic sheep carry a gene for a human blood protein – This protein may help in the treatment of cystic fibrosis
Other benefits of GMOs Disease resistance There are many viruses, fungi, bacteria that cause plant diseases “Super-shrimp” Cold tolerance Antifreeze gene from cold water fish introduced to tobacco and potato plants Drought tolerance & Salinity tolerance As populations expand, potential to grow crops in otherwise inhospitable environments
Downsides??? Introduce allergens? Pass trans-genes to wild populations? – Pollinator transfer R&D is costly – Patents to insure profits • Patent infringements • Lawsuits • potential for capitalism to overshadow humanitarian efforts
Application in medicine Human Gene Therapy Diagnosis of genetic disorders Forensic Evidence
Human Gene Therapy Human gene therapy seeks to repair the damage caused by a genetic deficiency through introduction of a functional version of the defective gene. To achieve this end, a cloned variant of the gene must be incorporated into the organism in such a manner that it is expressed only at the proper time and only in appropriate cell types. At this time, these conditions impose serious technical and clinical difficulties.
Gene therapy is the alteration of an afflicted individual’s genes Gene therapy holds great potential for treating disorders traceable to a single defective gene Vectors are used for delivery of genes into cells Gene therapy raises ethical questions, such as whether human germ-line cells should be treated to correct the defect in future generations
Many gene therapies have received approval from the National Institutes of Health for trials in human patients, including the introduction of gene constructs into patients. Among these are constructs designed to cure ADA- SCID (severe combined immunodeficiency due to adenosine deaminase [ADA] deficiency), neuroblastoma, or cystic fibrosis, or to treat cancer through expression of the E1A and p53 tumor suppressor genes.
Cloned gene Insert RNA version of normal allele into retrovirus. Viral RNA Let retrovirus infect bone marrow cells Retrovirus that have been removed from the capsid patient and cultured. Somatic cells Only! Viral DNA carrying the normal allele inserts into chromosome. Not for reproductive Bone marrow cells !! cell from patient Bone Inject engineered marrow cells into patient.
You can also read